45 cases on record
- Cases on record
- 45
- As claimant
- 13
- As respondent
- 32
- Patents held
- Not recorded
- Core tech
- Not recorded
| Case no. | Parties | Role | Court | Filed | Duration | Outcome |
|---|---|---|---|---|---|---|
| 1:25-cv-05870 | Mylan v. Alora Pharmaceuticals, LLC | Plaintiff | N.D. Ga. | 13 Oct 2025 | 30 d | Voluntary dismissal |
| 1:25-cv-00024 | Salix Pharmaceuticals, Inc. v. Mylan, NV | Defendant | N.D. W. Va. | 26 Mar 2025 | 190 d | Case Settled |
| 1:25-cv-00003 | Bausch Health Ireland, Ltd. v. Mylan, NV | Defendant | N.D. W. Va. | 13 Jan 2025 | 121 d | Dismissed with Prejudice |
| 25-1252 | Mylan, NV v. Janssen Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 5 Dec 2024 | 215 d | Appeal Dismissed |
| 24-2082 | Mylan, NV v. Regeneron Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 16 Jul 2024 | 197 d | Unpatentable |
| 1:24-cv-00067 | Novo Nordisk A/S v. Mylan, NV | Defendant | N.D. W. Va. | 2 Jul 2024 | 34 d | Voluntary dismissal |
| 1:24-cv-00775 | Novo Nordisk A/S v. Mylan, NV | Defendant | D. Del. | 1 Jul 2024 | 93 d | Dismissed without Prejudice |
| 24-2019 | Mylan, NV v. Regeneron Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 28 Jun 2024 | 215 d | Unpatentable |
| 24-2009 | Mylan, NV v. Regeneron Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 26 Jun 2024 | 217 d | Appeal Dismissed |
| 24-2002 | Mylan, NV v. Regeneron Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 25 Jun 2024 | 295 d | Voluntary dismissal |
| 24-1965 | Mylan, NV v. Regeneron Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 20 Jun 2024 | 223 d | Appeal Dismissed |
| 1:24-cv-00036 | Bausch Health Ireland, Ltd. v. Mylan, NV | Defendant | N.D. W. Va. | 5 Apr 2024 | 404 d | Dismissed with Prejudice |
| 24-1641 | Actelion Pharmaceuticals, Ltd. v. Mylan, NV | Defendant | Fed. Cir. | 2 Apr 2024 | 771 d | Appeal Dismissed |
| 24-1564 | Regeneron Pharmaceuticals, Inc. v. Mylan, NV | Defendant | Fed. Cir. | 13 Mar 2024 | 160 d | Voluntary dismissal |
| 24-1567 | Regeneron Pharmaceuticals, Inc. v. Mylan, NV | Defendant | Fed. Cir. | 13 Mar 2024 | 160 d | Voluntary dismissal |
| 24-1405 | Mylan, NV v. Regeneron Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 30 Jan 2024 | 73 d | Appeal Dismissed |
| 1:24-cv-00050 | Novo Nordisk A/S v. Mylan, NV | Defendant | D. Del. | 12 Jan 2024 | 434 d | Dismissed without Prejudice |
| 1:24-cv-00043 | Heron Therapeutics, Inc. v. Mylan, NV | Defendant | D. Del. | 11 Jan 2024 | 585 d | Case Consolidated |
| 1:23-cv-00088 | Actelion Pharmaceuticals, Ltd. v. Mylan, NV | Defendant | N.D. W. Va. | 7 Nov 2023 | 318 d | Consent Judgment |
| 24-1011 | Mylan, NV v. Bausch Health Ireland, Ltd. | Plaintiff | Fed. Cir. | 4 Oct 2023 | 593 d | Voluntary dismissal |
| 23-2434 | Bayer AG v. Mylan, NV | Defendant | Fed. Cir. | 28 Sep 2023 | 726 d | Appeal Dismissed in Part |
| 1:23-cv-01015 | Heron Therapeutics, Inc. v. Mylan, NV | Defendant | D. Del. | 15 Sep 2023 | 599 d | Dismissed without Prejudice |
| 23-2260 | Novartis, AG v. Mylan, NV | Defendant | Fed. Cir. | 9 Aug 2023 | 210 d | Appeal Dismissed |
| 23-2042 | Mylan, NV v. Janssen Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 20 Jun 2023 | 647 d | Appeal Dismissed |
| 1:23-cv-00556 | Mylan, NV v. Bayer AG | Plaintiff | D. Del. | 19 May 2023 | 300 d | Voluntary dismissal |
| 23-1395 | Regeneron Pharmaceuticals, Inc. v. Mylan, NV | Defendant | Fed. Cir. | 13 Jan 2023 | 543 d | Unpatentable |
| 2:22-cv-00216 | UCB Pharma, Gmbh v. Mylan, NV | Defendant | D. Vt. | 12 Dec 2022 | 567 d | Consent Judgment |
| 1:22-cv-01367 | Otsuka Pharmaceutical Co., Ltd. v. Mylan, NV | Defendant | D. Del. | 17 Oct 2022 | 591 d | Dismissed without Prejudice |
| 1:22-cv-01228 | Bayer AG v. Mylan, NV | Defendant | D. Del. | 21 Sep 2022 | 1184 d | Dismissed with Prejudice |
| 1:22-cv-01226 | Otsuka Pharmaceutical Co., Ltd. v. Mylan, NV | Defendant | D. Del. | 20 Sep 2022 | 618 d | Dismissed without Prejudice |
| 1:22-cv-00089 | Otsuka Pharmaceutical Co., Ltd. v. Mylan, NV | Defendant | N.D. W. Va. | 9 Sep 2022 | 179 d | Consent Judgment |
| 1:22-cv-00085 | Bausch Health Ireland, Ltd. v. Mylan, NV | Defendant | N.D. W. Va. | 1 Sep 2022 | 986 d | Case Dismissed |
| 1:22-cv-01125 | Otsuka Pharmaceutical Co., Ltd. v. Mylan, NV | Defendant | D. Del. | 26 Aug 2022 | 643 d | Case Dismissed |
| 1:22-cv-00061 | Regeneron Pharmaceuticals, Inc. v. Mylan, NV | Defendant | N.D. W. Va. | 2 Aug 2022 | 994 d | Dismissed with Prejudice |
| 22-1889 | Mylan, NV v. Actelion Pharmaceuticals, Ltd. | Plaintiff | Fed. Cir. | 10 Jun 2022 | 514 d | Vacated and Remanded |
| 1:22-cv-00032 | Otsuka Pharmaceutical Co., Ltd. v. Mylan, NV | Defendant | N.D. W. Va. | 8 Apr 2022 | 333 d | Consent Judgment |
| 1:22-cv-00464 | Otsuka Pharmaceutical Co., Ltd. v. Mylan, NV | Defendant | D. Del. | 8 Apr 2022 | 783 d | Dismissed without Prejudice |
| 1:22-cv-00020 | Bausch Health Ireland, Ltd. v. Mylan, NV | Defendant | N.D. W. Va. | 9 Mar 2022 | 1162 d | Dismissed with Prejudice |
| 22-1307 | Mylan, NV v. Janssen Pharmaceuticals, Inc. | Plaintiff | Fed. Cir. | 28 Dec 2021 | 825 d | Appeal Dismissed in Part |
| 21-2336 | UCB Pharma, Gmbh v. Mylan, NV | Defendant | Fed. Cir. | 22 Sep 2021 | 567 d | Appeal Dismissed |
| 21-1981 | Sanofi v. Mylan, NV | Defendant | Fed. Cir. | 28 May 2021 | 711 d | Case Reversed |
| 2:20-cv-13103 | Janssen Pharmaceuticals, Inc. v. Mylan, NV | Defendant | D.N.J. | 23 Sep 2020 | 972 d | Judgment on the merits for Plaintiff |
| 1:20-cv-00110 | Actelion Pharmaceuticals, Ltd. v. Mylan, NV | Defendant | N.D. W. Va. | 9 Jun 2020 | 1378 d | Judgment on the merits for Defendant |
| 1:20-cv-00019 | Boehringer-Ingelheim v. Mylan, NV | Defendant | N.D. W. Va. | 5 Feb 2020 | 2119 d | Consent Judgment |
| 1:19-cv-00101 | Merck Sharp & Dohme Co., Inc. v. Mylan, NV | Defendant | N.D. W. Va. | 2 May 2019 | 1461 d | Case Settled |
Source: Patsnap Litigation Data. Cases naming Mylan, NV in the current snapshot.
Run this in Eureka
Patsnap Eureka
See what Mylan is protecting
Portfolio, claim scope and where its coverage is thin. Every answer cites the records behind it.
Analyse this portfolio10,000 free credits to start
Mylan
Map this dispute space
- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Disclaimer. This page indexes publicly available court docket data and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Coverage has limits. Records come from a snapshot and may lag live dockets. Sealed filings, amended complaints and post-closure motions may not be reflected, and a case missing from this list is not evidence that it does not exist. Counts on this page describe what the snapshot contains, nothing more.
No characterisation of any party. Appearing on this page means a party is named in a docket record. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, or that any party prevailed.